Trials / Terminated
TerminatedNCT04774809
Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo
A Randomized, Double-blind, Vehicle-Controlled, Phase II/Ⅲ Seamless Adaptive Clinical Trail to Evaluate the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo
- Status
- Terminated
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Reistone Biopharma Company Limited · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the efficacy and safety of SHR0302 ointment in adult patients with Vitiligo.
Detailed description
This study is a phase II/Ⅲ seamless adaptive clinical trial to evaluate the efficacy and safety of SHR0302 ointment in adult patients with non-segmental vitiligo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Low Dose SHR0302 Ointment BID | Low Dose SHR0302 Ointment BID |
| DRUG | High Dose SHR0302 Ointment BID | High Dose SHR0302 Ointment BID |
| OTHER | Placebo Comparator: Vehicle | Placebo |
Timeline
- Start date
- 2020-01-29
- Primary completion
- 2022-03-21
- Completion
- 2022-03-21
- First posted
- 2021-03-01
- Last updated
- 2022-07-13
Locations
16 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04774809. Inclusion in this directory is not an endorsement.